The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Arcutis Biotherapeutics Inc’s current trading price is -0.99% away from its 52-week high, while its distance from the 52-week low is 640.91%. The stock’s price range for this period has been between $1.76 and $13.17 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.56 million for the day, a number notably higher than the average daily volume of 1.96 million over the last three months.
Arcutis Biotherapeutics Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $13.17 on 11/29/24 and the lowest value was $1.76 on 12/01/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Arcutis Biotherapeutics Inc (ARQT) has experienced a quarterly rise of 19.85% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.70B and boasts a workforce of 296 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.80, with a change in price of +3.23. Similarly, Arcutis Biotherapeutics Inc recorded 2,094,176 in trading volume during the last 100 days, posting a change of +32.93%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ARQT stands at 1.33. Similarly, the long-term debt-to-equity ratio is also 0.69.
ARQT Stock Stochastic Average
As of today, Arcutis Biotherapeutics Inc’s raw stochastic average for the last 50 days stands at 91.59%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 91.17%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 93.97% and 93.30%, respectively.
ARQT Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a gain of 303.72%.However, over the last six months, we can see a weaker performance of 55.98%. Over the last 30 days, the price of ARQT has fallen by 53.05%. And in the last five days, it has surged by 27.34%.
